Exact Sciences clears big hurdle on the path to FDA review

Exact Sciences, located at URP, successfully cleared another hurdle in the rollout of its Cologuard product, a non-invasive screening test for colorectal cancer. Next week, an FDA panel will review Exact Sciences’ pre-market approval application. Read more

Comments are closed.